NCT01367548View on ClinicalTrials.gov

Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Postoperative Ileus
Interventions
DRUG

IV Methylnaltrexone (MNTX)

DRUG

Placebo

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01367548 - Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus | Biotech Hunter | Biotech Hunter